Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

INSMED INC (INSM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

INSMED INC (INSM), most recent 12 months reported: revenue $1.14B, net loss $875.31M, free cash flow -$807.67M. Latest balance sheet on file: liquid cash $1.16B, total debt $543.51M, net cash $616.8M. From SEC filings. More on INSMED INC: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Phibro Animal Health Corporation · Indivior Pharmaceuticals, Inc. · MADRIGAL PHARMACEUTICALS, INC. · ACADIA PHARMACEUTICALS INC. · PRESTIGE CONSUMER HEALTHCARE INC. · PTC Therapeutics, Inc. · ANI PHARMACEUTICALS, INC · HARMONY BIOSCIENCES HOLDINGS, INC.

Stock screener

Watchlist